Scaling Gallium-68 Production in the UK: Building Reliable Diagnostic Supply for the Next Generation of Radiopharmaceutical Development

11:00 am - Wednesday 2nd December 2026

  • Exploring the growing importance of Gallium-68 imaging in radiopharmaceutical clinical development and patient selection strategies
  • Navigating the operational, infrastructure and regulatory considerations required to establish and expand Gallium-68 production capabilities
  • Discussing how developers, manufacturers and clinical centres can work together to address supply constraints and support future radiopharmaceutical growth

Speakers:

Radiopharmaceutical Scientist (Clinical Trials)
The Royal Marsden